Europe Cardiac AI Monitoring and Diagnostics Market - Analysis and Forecast, 2023-2032
상품코드:1393908
리서치사:BIS Research
발행일:2023년 12월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
유럽의 심장 AI 모니터링 및 진단 시장 규모는 2022년 2억 7,560만 달러에서 예측 기간 동안 28.09%의 CAGR을 기록하며 2032년에는 31억 9,990만 달러 규모로 성장할 것으로 예상됩니다.
세계 심혈관 질환의 높은 유병률, AI 도입을 위한 정부 이니셔티브 확대, 심장 AI 분야 연구 확대, 심장 질환 진단을 위한 AI 의료기기 승인 증가, 심장 AI 진단 분야 기술 발전 등이 시장 성장의 주요 요인으로 작용하고 있습니다.
본 보고서는 유럽의 심장 AI 모니터링 및 진단 시장을 조사했으며, 시장 개요, 시장 성장에 영향을 미치는 각종 요인 분석, 특허 동향, 규제 환경, 사례 연구, 시장 규모 추이 및 예측, 각종 부문별·주요 국가별 상세 분석, 경쟁 상황, 주요 기업 분석 등의 정보를 정리하여 전해드립니다.
주요 시장 통계
예측 기간
2023-2032년
2023년 평가
3억 4,470만 달러
2032년 전망
31억 9,990만 달러
CAGR
28.09%
시장 분류
세분화 1: 제품별
소프트웨어
하드웨어
세분화 2: 유형별
심장질환 진단
영상 진단
심전도 기반
기타
심장 모니터링
세분화 3: 용도별
허혈성 심장질환/CAD
심장 부정맥
허혈성 뇌졸중
기타
세분화 4: 최종사용자별
병원
진단센터
기타
세분화 5: 국가별
독일
영국
프랑스
스페인
이탈리아
기타
목차
제1장 시장
시장 전망
제2장 업계 전망
주요 동향
기회 평가
규제 체계
특허 분석
비지니스 모델
사례 연구
사례 연구 1 : Ultromics Limited
사례 연구 2 : CorVista Health, Inc.
진행중인 임상시험
자금 조달 시나리오
최종사용자 인식
신규 참여자 참여 장벽
제3장 지역
유럽의 심장 AI 모니터링 및 진단 시장
주요 조사 결과와 기회 평가
디지털의 도입
시장 역학
시장 규모와 예측
제4장 시장 : 경쟁 벤치마킹과 기업 개요
액티브 기업 생태계
주요 전략·전개
기업 개요
Koninklijke Philips N.V.
Medicalgorithmics S.A.
Siemens Healthineers AG
Ultromics Limited.
ksm
영문 목차
영문목차
“The Europe Cardiac AI Monitoring and Diagnostics Market Expected to Reach $3,199.9 Million by 2032.”
Introduction to Europe Cardiac AI Monitoring and Diagnostics Market
The Europe cardiac AI monitoring and diagnostics market was valued at $275.6 million in 2022 and is anticipated to reach $3,199.9 million by 2032, witnessing a CAGR of 28.09% during the forecast period 2023-2032. The high prevalence of cardiovascular diseases worldwide, rising government initiatives for AI adoption, expanding research in the field of AI for cardiology, rising regulatory approvals of cardiac diagnostics AI medical devices, and technological advancements in the field of cardiac AI diagnostics are the main factors propelling the growth of the europe market for cardiac AI monitoring and diagnostics.
KEY MARKET STATISTICS
Forecast Period
2023 - 2032
2023 Evaluation
$344.7 Million
2032 Forecast
$3,199.9 Million
CAGR
28.09%
Market Introduction
The market for cardiac AI monitoring and diagnostics in Europe has grown and advanced significantly in recent years. Cardiologists are using artificial intelligence (AI) technology more and more to improve diagnoses and monitoring for a range of heart diseases.
Vast volumes of patient data, like as electrocardiograms (ECGs), imaging scans, and patient histories, can be analyzed by AI-powered cardiac monitoring systems in order to find and identify anomalies or possible cardiac diseases. These technologies can enhance patient outcomes, offer prompt and accurate diagnoses, and support healthcare personnel in making decisions by utilizing AI algorithms and machine learning.
There are many benefits of using AI in cardiac monitoring and diagnostics. It makes patient data analysis more thorough and efficient, which helps identify cardiac problems early on, which is essential for prompt intervention and treatment. In addition, AI algorithms can help with risk management and stratification by locating high-risk patients and enhancing treatment regimens.
Furthermore, telehealth applications in the field of cardiology and remote monitoring are made possible by AI technology. AI-enabled wearables and sensors can send real-time data to healthcare providers while continuously monitoring a patient's heart parameters. This enhances patient access to care and lowers healthcare costs by enabling remote management of chronic illnesses, early detection of arrhythmias or cardiac events, and remote monitoring of high-risk patients.
Technology businesses, healthcare providers, and research organizations are investing heavily and collaborating in the European cardiac AI monitoring and diagnostics industry. A favorable regulatory environment, rising cardiovascular disease prevalence, and growing demand for sophisticated cardiac monitoring and diagnostics are propelling the market expansion in the area.
But there are still issues to be resolved, like worries about data security and privacy, a lack of compatibility between various AI systems, and the requirement for thorough assessment and legal clearance of AI algorithms. Standardized methods and recommendations for the application of AI in cardiac monitoring and diagnostics are being developed in order to guarantee patient safety and encourage broad adoption among European nations.
Market Segmentation:
Segmentation 1: by Product
Software
Hardware
Segmentation 2: by Type
Cardiac Diagnostics
Imaging
ECG-Based
Others
Cardiac Monitoring
Segmentation 3: by Application
Ischemic Heart Disease/CAD
Cardiac Arrhythmias
Ischemic Stroke
Others
Segmentation 4: by End User
Hospitals
Diagnostic Centers
Other End Users
Segmentation 5: by Country
Germany
U.K.
France
Spain
Italy
Rest-of-Europe
How Can This Report Add Value to an Organization?
Product/Innovation Strategy: The europe cardiac AI monitoring and diagnostics market has been extensively segmented based on various categories, such as products, types, applications, end users, and regions. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and regional presence.
Some of the prominent names in this market are:
Koninklijke Philips N.V.
Medicalgorithmics S.A.
Siemens Healthineers AG
Ultromics Limited.
Table of Contents
1 Market
1.1 Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion Criteria
1.1.3 Exclusion Criteria
1.1.4 Overview
1.1.4.1 Market Size and Growth Potential
2 Industry Outlook
2.1 Key Trends
2.1.1 Rising Number of Startups in the Market
2.1.2 Increased Awareness Regarding Preventative Measures and Personalized Treatment
2.1.3 Growing Demand for Wearable Sensors for Cardiac Monitoring Leading to Increased Adoption of AI-Enabled Solutions for Home-Based Care
2.2 Opportunity Assessment
2.3 Regulatory Framework
2.3.1 Regulatory Framework for Artificial Intelligence-Based FDA-Approved Medical Devices and Algorithms
2.3.2 Regulatory Framework in the U.S.
2.3.3 Regulatory Framework in Europe
2.3.4 Regulatory Framework in Japan
2.3.5 Regulatory Framework in China
2.3.6 Regulatory Framework in the Other Countries
2.4 Patent Analysis
2.4.1 Awaited Technological Developments
2.4.1.1 Patent Analysis (by Country)
2.4.1.2 Patent Analysis (by Year)
2.5 Business Models
2.6 Case Studies
2.6.1 Case Study 1: Ultromics Limited
2.6.1.1 The EchoGo System
2.6.1.1.1 Developement
2.6.1.1.2 Use Case and Reliability
2.6.1.2 A Success Story
2.6.1.3 Partners and Recognitions
2.6.2 Case Study 2: CorVista Health, Inc.
2.6.2.1 The CorVista System
2.6.2.2 A Success Story
2.7 Ongoing Clinical Trials
2.8 Funding Scenario
2.9 End User Perception
2.1 Entry Barriers for New Entrants
3 Regions
3.1 Europe Cardiac AI Monitoring and Diagnostics Market
3.1.1 Key Findings and Opportunity Assessment
3.1.2 Digital Adoption
3.1.3 Market Dynamics
3.1.3.1 Impact Analysis
3.1.4 Market Sizing and Forecast
3.1.4.1 Europe Cardiac AI Monitoring and Diagnostics Market (by Product)
3.1.4.2 Europe Cardiac AI Monitoring and Diagnostics Market (by Type)
3.1.4.2.1 Europe Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
3.1.4.3 Europe Cardiac AI Monitoring and Diagnostics Market (by Application)
3.1.4.4 Europe Cardiac AI Monitoring and Diagnostics Market (by End User)
3.1.4.5 Europe Cardiac AI Monitoring and Diagnostics Market (by Country)
3.1.4.5.1 Germany
3.1.4.5.1.1 Market Dynamics
3.1.4.5.1.2 Market Size and Forecast
3.1.4.5.1.2.1 Germany Cardiac AI Monitoring and Diagnostics Market (by Product)
3.1.4.5.1.2.2 Germany Cardiac AI Monitoring and Diagnostics Market (by Type)
3.1.4.5.1.2.2.1 Germany Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
3.1.4.5.1.2.3 Germany Cardiac AI Monitoring and Diagnostics Market (by Application)
3.1.4.5.1.2.4 Germany Cardiac AI Monitoring and Diagnostics Market (by End User)
3.1.4.5.2 U.K.
3.1.4.5.2.1 Market Dynamics
3.1.4.5.2.2 Market Size and Forecast
3.1.4.5.2.2.1 U.K. Cardiac AI Monitoring and Diagnostics Market (by Product)
3.1.4.5.2.2.2 U.K. Cardiac AI Monitoring and Diagnostics Market (by Type)
3.1.4.5.2.2.2.1 U.K. Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
3.1.4.5.2.2.3 U.K. Cardiac AI Monitoring and Diagnostics Market (by Application)
3.1.4.5.2.2.4 U.K. Cardiac AI Monitoring and Diagnostics Market (by End User)
3.1.4.5.3 France
3.1.4.5.3.1 Market Dynamics
3.1.4.5.3.2 Market Size and Forecast
3.1.4.5.3.2.1 France Cardiac AI Monitoring and Diagnostics Market (by Product)
3.1.4.5.3.2.2 France Cardiac AI Monitoring and Diagnostics Market (by Type)
3.1.4.5.3.2.2.1 France Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
3.1.4.5.3.2.3 France Cardiac AI Monitoring and Diagnostics Market (by Application)
3.1.4.5.3.2.4 France Cardiac AI Monitoring and Diagnostics Market (by End User)
3.1.4.5.4 Italy
3.1.4.5.4.1 Market Dynamics
3.1.4.5.4.2 Market Size and Forecast
3.1.4.5.4.2.1 Italy Cardiac AI Monitoring and Diagnostics Market (by Product)
3.1.4.5.4.2.2 Italy Cardiac AI Monitoring and Diagnostics Market (by Type)
3.1.4.5.4.2.2.1 Italy Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
3.1.4.5.4.2.3 Italy Cardiac AI Monitoring and Diagnostics Market (by Application)
3.1.4.5.4.2.4 Italy Cardiac AI Monitoring and Diagnostics Market (by End User)
3.1.4.5.5 Spain
3.1.4.5.5.1 Market Dynamics
3.1.4.5.5.2 Market Size and Forecast
3.1.4.5.5.2.1 Spain Cardiac AI Monitoring and Diagnostics Market (by Product)
3.1.4.5.5.2.2 Spain Cardiac AI Monitoring and Diagnostics Market (by Type)
3.1.4.5.5.2.2.1 Spain Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
3.1.4.5.5.2.3 Spain Cardiac AI Monitoring and Diagnostics Market (by Application)
3.1.4.5.5.2.4 Spain Cardiac AI Monitoring and Diagnostics Market (by End User)
3.1.4.5.6 Rest-of-Europe
3.1.4.5.6.1 Market Size and Forecast
3.1.4.5.6.1.1 Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Product)
3.1.4.5.6.1.2 Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Type)
3.1.4.5.6.1.2.1 Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
3.1.4.5.6.1.3 Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Application)
3.1.4.5.6.1.4 Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by End User)
4 Markets - Competitive Benchmarking & Company Profiles
4.1 Cardiac AI Monitoring and Diagnostics Active Players Ecosystem
4.2 Key Strategies and Developments
4.2.1 Regulatory and Legal Activities
4.2.2 Partnerships, Alliances, and Business Expansions
4.2.3 Funding Activities
4.2.4 New Offerings
4.2.5 Mergers and Acquisitions
4.3 Company Profiles
4.3.1 Koninklijke Philips N.V.
4.3.1.1 Company Overview
4.3.1.2 Role of Koninklijke Philips N.V. in the Cardiac AI Monitoring and Diagnostics Market
4.3.1.3 Financials
4.3.1.4 Key Developments
4.3.1.5 Analyst Perception
4.3.2 Medicalgorithmics S.A.
4.3.2.1 Company Overview
4.3.2.2 Role of Medicalgorithmics S.A. in the Cardiac AI Monitoring and Diagnostics Market
4.3.2.3 Key Developments
4.3.2.4 Analyst Perception
4.3.3 Siemens Healthineers AG
4.3.3.1 Company Overview
4.3.3.2 Role of Siemens Healthineers AG in the Cardiac AI Monitoring and Diagnostics Market
4.3.3.3 Financials
4.3.3.4 Analyst Perception
4.3.4 Ultromics Limited.
4.3.4.1 Company Overview
4.3.4.2 Role of Ultromics Limited. in the Cardiac AI Monitoring and Diagnostics Market
